These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 34417976

  • 1. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y, Peng F, Tan X, Wang J, Xu Y.
    Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
    [Abstract] [Full Text] [Related]

  • 2. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
    Wu XL, Wang LK, Yang DD, Qu M, Yang YJ, Guo F, Han L, Xue J.
    J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
    [Abstract] [Full Text] [Related]

  • 3. P300 increases CSNK2A1 expression which accelerates colorectal cancer progression through activation of the PI3K-AKT-mTOR axis.
    Liu J.
    Exp Cell Res; 2023 Sep 01; 430(1):113694. PubMed ID: 37391010
    [Abstract] [Full Text] [Related]

  • 4. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F, Huang X, Xuan Y.
    Dis Markers; 2021 Sep 01; 2021():9950663. PubMed ID: 34512817
    [Abstract] [Full Text] [Related]

  • 5. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
    Tao SN, Liu XC, Wang YY, Yang H.
    Zhonghua Yi Xue Za Zhi; 2024 Mar 12; 104(10):758-765. PubMed ID: 38462356
    [Abstract] [Full Text] [Related]

  • 6. Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway.
    Zhu Y, Zhong Y, Long X, Zhu Z, Zhou Y, Ye H, Zeng X, Zheng X.
    Pharm Biol; 2019 Dec 12; 57(1):412-423. PubMed ID: 31230505
    [Abstract] [Full Text] [Related]

  • 7. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J, Zhao X, Jiang H, Yang T, Li D, Yang X, Jia A, Ma Y, Qian Z.
    Tissue Cell; 2022 Aug 12; 77():101817. PubMed ID: 35679685
    [Abstract] [Full Text] [Related]

  • 8. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ, Xu WR, Chen B, Wang YY, Yang N, Wang LJ, Zhang YL.
    Eur Rev Med Pharmacol Sci; 2019 Oct 12; 23(19):8321-8331. PubMed ID: 31646562
    [Abstract] [Full Text] [Related]

  • 9. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells.
    Li Q, Tang H, Hu F, Qin C.
    J Cell Biochem; 2019 Mar 12; 120(3):3853-3860. PubMed ID: 30321450
    [Abstract] [Full Text] [Related]

  • 10. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S, Huang W, Liu X, Liu X, Chen N, Xu Q, Hu Y, Song W, Zhou J.
    J Exp Clin Cancer Res; 2018 Dec 05; 37(1):304. PubMed ID: 30518405
    [Abstract] [Full Text] [Related]

  • 11. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
    Hu F, He Z, Sun C, Rong D.
    Gene; 2019 Jun 05; 700():96-104. PubMed ID: 30917932
    [Abstract] [Full Text] [Related]

  • 12. Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells.
    Wang H, Duan L, Zou Z, Li H, Yuan S, Chen X, Zhang Y, Li X, Sun H, Zha H, Zhang Y, Zhou L.
    Int J Med Sci; 2014 Jun 05; 11(8):841-9. PubMed ID: 24936148
    [Abstract] [Full Text] [Related]

  • 13. Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cells.
    Yao W, Lin Z, Shi P, Chen B, Wang G, Huang J, Sui Y, Liu Q, Li S, Lin X, Liu Q, Yao H.
    Biochem Pharmacol; 2020 Jan 05; 171():113680. PubMed ID: 31669234
    [Abstract] [Full Text] [Related]

  • 14. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
    Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B, Jia L.
    J Hematol Oncol; 2018 Jul 03; 11(1):89. PubMed ID: 29970122
    [Abstract] [Full Text] [Related]

  • 15. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway.
    Chang L, Wu P, Senthilkumar R, Tian X, Liu H, Shen X, Tao Z, Huang P.
    J Cancer Res Clin Oncol; 2016 Jan 03; 142(1):59-72. PubMed ID: 26109148
    [Abstract] [Full Text] [Related]

  • 16. Leukotriene B4 receptor knockdown affects PI3K/AKT/mTOR signaling and apoptotic responses in colorectal cancer.
    Tang C, Wang A, Zhao Y, Mou W, Jiang J, Kuang J, Sun B, Tang E.
    Biomol Biomed; 2024 Jan 20; 24(4):968-981. PubMed ID: 38259082
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. B7-H4 facilitates proliferation and metastasis of colorectal carcinoma cell through PI3K/Akt/mTOR signaling pathway.
    Li C, Zhan Y, Ma X, Fang H, Gai X.
    Clin Exp Med; 2020 Feb 20; 20(1):79-86. PubMed ID: 31664539
    [Abstract] [Full Text] [Related]

  • 19. [Mechanism of Huachansu Injection against colorectal cancer based on network pharmacology and cellular experimental].
    Meng ZY, Zhao J, Zhu QF, Xiang DF, Meng JJ, Chen JJ, Jiang B, Hu YJ, Xu LY, Zhang XQ, Zou H, Han YL.
    Zhongguo Zhong Yao Za Zhi; 2024 Sep 20; 49(17):4755-4767. PubMed ID: 39307810
    [Abstract] [Full Text] [Related]

  • 20. The role of c2orf68 and PI3K/Akt/mTOR pathway in human colorectal cancer.
    Wen X, Zhu J, Dong L, Chen Y.
    Med Oncol; 2014 Aug 20; 31(8):92. PubMed ID: 25023051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.